How COVID-19 can increase asthma related problems?

The Hidden Agenda Of How COVID-19 Can Increase Asthma Related Problems?

World Asthma Day is celebrated to inform people to the doctor and inform them about the problems caused by the disease. In 2022, this day is celebrated on the day, that is, May 3. It affects the lungs of the person with Asthma. It is a chronic illness that causes coughing, breast milk, diarrhea, and crying. Asthma can be made worse by COVID-19 and can cause more complications for the person with it.

COVID-19 can make medical symptoms worse, and it can also make those symptoms worse. According to the Centers for Disease Control and Prevention (CDC), COVID-19 may prevent health problems in people with cancer. In addition, it can also cause pneumonia, which can be detrimental to health.

ALSO VIEW :- The enemies of the heart are diabetes and obesity

Symptoms: 

Symptoms of COVID-19 include fever, cough, sore throat, headache, loss of taste or smell, nausea, and muscle aches. People with the disorder should take special care of themselves and listen to the following evidence.

-breathlessness

-more use of an inhaler

-increase in chest tightness or wheezing

-coughing

 Precautions:

-Follow all the recommendations for preventing COVID-19 infection. These recommendations include washing hands frequently, wearing a face mask, social distancing, vaccination, etc.

 -Avoid the potential asthma triggers including, smoke, dust mites, stress, strong fragrances, alcohol, etc.

 -People suffering from asthma should take all the medications given to them by the doctor.

 YOU MAY LIKE THIS :-  What To Feed And Avoid For Proper Nutrition In Children?

Treatment:

 -If you are suffering from COVID-19, isolate yourself and rest.

 -Drink more water as dehydration can make the symptoms worse.

 -Take your doctor's recommendations if the medicines are required. People, who have asthma, are more likely to get their health worsen if they would suffer from COVID-19.

 -Contact your doctor if you face any symptoms of COVID-19 and are suffering from asthma as well.

 -Don't stop your asthma medication.

 -Try to avoid a stressful situation.

 -Avoid the potential asthma triggers.

 -If the asthma medications do not help you, contact the doctor right away.

CONCLUSION :-

World Asthma Day is celebrated to inform people to the doctor and inform them about the problems caused by the disease. It affects the lungs of the person with Asthma. COVID-19 can make medical symptoms worse, and it can also make those symptoms worse. According to the Centers for Disease Control and Prevention (CDC), COVID-19 may prevent health problems in people with cancer. People with the disorder should take special care of themselves and listen to the following evidence. -Follow all the recommendations for preventing COVID-19 infection.

 RECOMMENDED VIDEO :- What is asthma & how does COVID-19 affect it?

 VISIT OFFICIAL WEBSITE :- https://www.apnahealthwealthcare.com/

 SOURCE :- DAINIK JAGRAN

 

  

 Corona drug question: Some people relapse after taking a Pfizer pill; Health experts question its effectiveness

In many countries, Paxlovid injections are prescribed for people with mild coronary symptoms. It is manufactured by the American pharmaceutical company Pfizer. In April, the pill has also received approval from the Drug Controller General of India (DCGI). However, there are now reports that in some cases coronary artery disease returns in patients after recovery after taking the pill.

According to a report by the AP news agency, the Paxlovid pill has become a household name for coronavirus patients in America. On the one hand, the government has spent $10 billion so far to buy PaxLovid. This can save 2 million lives.And health experts are now questioning the efficacy of this drug ie Efficacy.

What's the matter?

In some patients, the infection is recurring even after 5 days of taking Paxlovid tablet as a rule. This raises two kinds of questions. First- Do patients get sick even after taking the drug? Second- the patient must repeat the entire course of Paxlovid.

The United States Food and Drug Administration (FDA) says- Patients should avoid taking a double course of tablets. In fact, people with recurrent coronary symptoms are at increased risk of serious illness and hospitalization. In such a situation, first medical advice is required.

Paxlovid tablet effective against delta variant

Clinical trials of the Paxlovid tablet were conducted by the Pfizer Company at a time when the world was struggling with the Delta variant. At that time most people did not even receive the vaccine. In its trial, Pfizer tested Paxlovid in unvaccinated coronary patients who had severe infections and were at risk for diseases such as heart disease and diabetes. The drug increased the risk of hospitalization and death for patients from 7% to 1%.

Today the situation is different. About 90% of people in the United States have been given their first dose of the vaccine. 60% of Americans have had Corona at least once. The hospitalization rate of vaccinated individuals is also less than 1%. In such a case, health professionals are raising questions about the effect of Paxlovid tablet on them.

Health experts are criticizing the tablet

Dr. A.S. Michael Charnes of Boston’s VA Health System said – Paxlovid is a very effective drug, but perhaps weakens against the Omicron variant. This is the reason that in some patients the symptoms of corona start coming again. On the other hand, both the FDA and Pfizer have reported that even in early studies with the tablet, 1-2% of people had problems with coronary symptoms that returned 10 days after recovery from infection.

According to Andy Pekosz of John Hopkins University, the Paxovid tablet may not be as effective at relieving the symptoms of the virus as before. They fear that as a result new corona strains may appear in the patient’s body, which could prove to be a threat in the future in defeating PaxLovid.

University of Minnesota researcher David Bolware says – If the US government is spending this much money on this tablet, then Pfizer needs to do new research and share the data with the government and help formulate better policy against the epidemic.

pfizer cleaning

Pfizer recently reported that giving PaxLovid to families of coronary patients does not reduce their risk of infection. The company also made it clear last year that PaxLovid appears to be failing to control the symptoms of patients with coronary artery disease and reduce hospital admissions. So he is studying new variants of corona and the effect of Paxlovid tablet on vaccinated people. It will also be determined in the study whether this tablet is able to reduce the severity and duration of coronary artery disease.